+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astex Pharmaceuticals - logo

Astex Pharmaceuticals is a member of one of Japan's leading pharmaceutical companies, the Otsuka group. It focuses on developing small-molecule therapeutics with a focus on oncology and hematology. Its fragment-based drug discovery platform, Pyramid, has been successfully applied to therapeutic targets addressing a variety of disease areas. The company was formerly known as SuperGen Inc. and changed its name in September 2011. Astex was founded in 1991 and is headquartered in Dublin, California.

Fragment-Based Drug Discovery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Fragment-Based Drug Discovery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • July 2023
  • 117 Pages
  • Global
From
Colorectal Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3889 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3999 Pages
  • Global
From
Small-Cell Lung Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Small-Cell Lung Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1397 Pages
  • Global
From
Uveal Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Uveal Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 331 Pages
  • Global
From
Chronic Myelocytic Leukemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Chronic Myelocytic Leukemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 693 Pages
  • Global
From
Small Molecule Drug Discovery Global Market Report 2024 - Product Thumbnail Image

Small Molecule Drug Discovery Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2020 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3103 Pages
  • Global
From
Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Outsourcing in Drug Discovery, 9th Edition - Product Thumbnail Image

Outsourcing in Drug Discovery, 9th Edition

  • Report
  • June 2020
  • 294 Pages
  • Global
From
Myelodysplastic Syndromes: Opportunity Analysis and Forecasts to 2028 - Product Thumbnail Image

Myelodysplastic Syndromes: Opportunity Analysis and Forecasts to 2028

  • Report
  • May 2020
  • 193 Pages
  • Global
From
Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 116 Pages
  • Global
From
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 119 Pages
  • Global
From
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2020 in Pharmaceuticals - Product Thumbnail Image

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2020 in Pharmaceuticals

  • Report
  • March 2020
  • 85 Pages
  • Global
From
Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 29 Pages
From
Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report - Product Thumbnail Image

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

  • SWOT Analysis
  • September 2023
  • 37 Pages
From
Loading Indicator